News

Action Alert: Protect Ovarian Cancer Research Funding at th...

Action Alert: Protect Ovarian Cancer Research Funding at the Department of Defense

May 24, 2016

Later this week, we’ll be sending out a request for you to take Action to help protect ovarian cancer research funding at the Department of Defense. The Ovarian Cancer Research Program (OCRP) is part of the Congressionally Directed Medical Research Program in the Department of Defense (DoD), and funds innovative and cutting edge ovarian cancer … Continued

Newk's Unites 100 Restaurants to Raise $100,000 for Ov...

Newk's Unites 100 Restaurants to Raise $100,000 for Ovarian Cancer Research

May 20, 2016

Foodie Fast-Casual Brand Reaches Halfway Point in Its 200-Unit Growth Plan JACKSON, Miss. — Pairing a big moment with a big cause, fast-casual Newk’s Eatery is celebrating its centennial restaurant opening by uniting system-wide to raise $100,000 for ovarian cancer research starting April 4. Each of Newk’s 100 restaurants has committed to raising $1,000, inviting … Continued

Newk's Raises more than $110,000 for OCRFA

Newk's Raises more than $110,000 for OCRFA

May 20, 2016

When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis. Blindsided and heartbroken by a type of cancer very few recognize or understand, Lori and her husband Chris, Co-founder and CEO of Newk’s Eatery, saw an opportunity to save women’s … Continued

OCRFA Research Helps Explain Resistance to Chemotherapy

OCRFA Research Helps Explain Resistance to Chemotherapy

May 4, 2016

(May 4, 2016) Research funded in part by an OCRFA research grant to Dr. Weiping Zou at the University of Michigan has shown that the sensitivity and resistance to cancer chemotherapies is not fully explained by genomic mechanisms as it has previously thought.  In fact, it may be affected by effector T cells (cells that defend … Continued

Stand Up To Cancer Supports “Innovation in Collaboration” i...

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards

May 2, 2016

May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-­‐affiliated scientists. Each team, consisting of researchers from different SU2C-­‐supported “Dream Teams” or research programs, will receive a grant of $200,000 to support new research projects stemming … Continued

Stand Up To Cancer Supports “Innovation in Collaboration” i...

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research

May 2, 2016

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-affiliated scientists. Each team, consisting … Continued

OCRFA Statement on Results of GOG 252

OCRFA Statement on Results of GOG 252

April 11, 2016

Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. OCRFA consulted with a team of our scientific experts, and the consensus of the group is that the results of this … Continued

OCRFA Statement on Results of GOG 252

OCRFA Statement on Results of GOG 252

April 11, 2016

April 11, 2016 – Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. OCRFA consulted with a team of our scientific experts, and the consensus of the group is that … Continued

OCRFA Co-authors Paper on Educating about Hereditary Risk A...

OCRFA Co-authors Paper on Educating about Hereditary Risk Across Cancer Types

March 28, 2016

Ovarian Cancer Research Alliance today announced the online publication of a collaborative best practices paper entitled, “Understanding Hereditary Cancer in the Era of Multi-Gene Panel Testing.” The paper offers key insights into the changing needs of individuals and family members who might be at risk for hereditary cancer. The paper also includes discussion of how … Continued

Q&A with OCRFA Grantee Jill Madden, Ph.D.

Q&A with OCRFA Grantee Jill Madden, Ph.D.

March 18, 2016

Q&A with Jill Madden, PhD University of Kansas Medical Center Research Institute, Inc. 2016 Ann Schreiber Mentored Investigator Award   OCRFA: Tell me about yourself. Did you always want to be a scientist? Were you interested in science as a child? Jill Madden: I grew up on a farm in rural Alden, Iowa, where livestock … Continued

OCRF Research Illuminates Origins of PPM1D Mutations in Ova...

OCRF Research Illuminates Origins of PPM1D Mutations in Ovarian Cancer Patients

February 24, 2016

(February 24, 2016) Research led by Dr. Elizabeth Swisher at the University of Washington, funded in part by OCRFA and published this month in JAMA Oncology, shows that mutations in the gene PPM1D in women with ovarian cancer are the result of aging and chemotherapy exposure. Read the abstract in JAMA Oncology. Previously, somatic mosaic … Continued

OCRF Research Defines How Satb1 Gene Goes from Helpful to H...

OCRF Research Defines How Satb1 Gene Goes from Helpful to Harmful in Ovarian Cancer

February 22, 2016

(February 22, 2016) Imagine a lighthouse on cancer cells that can tell the T-cells in our immune system precisely where to attack to stop cancer in its tracks. When working properly, that’s exactly what dendritic cells do. They break down cancer cells into antigens that T-cells can “read” and know to attack while sparing healthy … Continued